Bioactive-Material-Programmed CAR-T Cell Living Drug for Augmented Immunotherapy against Tumors

0
20
Investigators summarize the use of bioactive-material-programmed CAR-T cells for disrupting tumor microenvironment barriers by modulating the immunosuppressive microenvironment, thus avoiding the side effects.
[Cell Reports Physical Science]
Full Article